original ) (raw )The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
Tim Karl
Current Pharmaceutical Design, 2012
View PDFchevron_right
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro , Francisco Navarrete
Neuropsychopharmacology, 2011
View PDFchevron_right
13.4 Cannabinoid Receptor Gene Polymorphisms and Cognitive Performance in Patients with Schizophrenia
João Salgado
Schizophrenia Bulletin, 2018
View PDFchevron_right
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Felipe Gomes
Philosophical Transactions of the Royal Society B: Biological Sciences, 2012
View PDFchevron_right
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids
Iain McGregor
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2011
View PDFchevron_right
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Onintza Sagredo
European Neuropsychopharmacology, 2020
View PDFchevron_right
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
Sándor Benyhe
View PDFchevron_right
Cannabinoid CB1 receptor: Role in primate prefrontal circuitry and schizophrenia
Stephen Eggan
2007
View PDFchevron_right
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
EVA MARIA MARCO LOPEZ
Frontiers in behavioral neuroscience, 2011
View PDFchevron_right
P.3.f.006 Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviours in mice
Antonio Ortega-Alvaro , Francisco Navarrete
European Neuropsychopharmacology, 2010
View PDFchevron_right
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich Olivares
Pharmaceuticals
View PDFchevron_right
Cellular Mechanisms Underlying the Anxiolytic Effect of Low Doses of Peripheral Δ9-Tetrahydrocannabinol in Rats
Tiziana Rubino , Daniela Braida
Neuropsychopharmacology, 2007
View PDFchevron_right
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
Frederico Ferreira
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2014
View PDFchevron_right
A behavioural comparison of acute and chronic delta-9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
Leonora Long
2010
View PDFchevron_right
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
Naielly Rodrigues
Pharmacological Research, 2020
View PDFchevron_right
Brain cannabinoid CB2 receptor in schizophrenia
Tadao Arinami
2010
View PDFchevron_right
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
Alejandro Rey
Neuropsychopharmacology, 2012
View PDFchevron_right
Using Knockout Mice Models to Explore Links between THC and Schizophrenia: A Research Protocol
Keerat Grewal
2019
View PDFchevron_right
Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence
Leonora Long
2013
View PDFchevron_right
Cannabinoid receptors and their relationships with neuropsychiatric disorders
Domenico De Berardis
International journal of immunopathology and pharmacology
View PDFchevron_right
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
Felipe Roberto Bozzo Gomes
Schizophrenia Research, 2015
View PDFchevron_right
Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders
Susana Aguilar Esteban
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012
View PDFchevron_right
Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.
Krisztina Monory
View PDFchevron_right
Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
Steven Laviolette
Neuroscience and biobehavioral reviews, 2016
View PDFchevron_right
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use
Michael Perdices
Schizophrenia Research and Treatment, 2011
View PDFchevron_right
Neurobehavioral effects of Δ9-THC and cannabinoid (CB1) receptor gene expression in mice
Emmanuel Onaivi
Behavioural Brain Research, 1995
View PDFchevron_right
Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice
Krisztina Monory
PLoS Biology, 2007
View PDFchevron_right